Pharmas rally to protect employees in Ukraine, along with support and donations to Russia-invaded country
As the biopharma industry monitors drug development and supply disruptions that might stem from the Russian invasion of Ukraine, individual pharma companies are working to ensure the safety of their employees in Ukraine — and in some cases, offer aid to the country under siege.
Boehringer Ingelheim said it is will contribute €2.5 million to humanitarian relief funds. A BI tweet on Sunday read in part: “We condemn the military aggression against Ukraine,” and added that along with the funding, it will “do everything we can to help our impacted colleagues, their families and communities.”
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 153,800+ biopharma pros reading Endpoints daily — and it's free.